Correction to “Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73”

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL Journal of Medicinal Chemistry Pub Date : 2024-09-30 DOI:10.1021/acs.jmedchem.4c02245
Cunjian Shi, Longfeng Chang, Jie Wang, Jingqi Dai, Wenyue Xu, Jiangyang Tang, Wenyi Mei, Chen Zhang, Zedong Wang, Yichen Liao, Xingsen Zhang, Wenzhe Jiang, Guozhen Zhang, Zhenjiang Zhao, Rui Wang, Yufang Xu, Lili Zhu, Honglin Li
{"title":"Correction to “Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73”","authors":"Cunjian Shi, Longfeng Chang, Jie Wang, Jingqi Dai, Wenyue Xu, Jiangyang Tang, Wenyi Mei, Chen Zhang, Zedong Wang, Yichen Liao, Xingsen Zhang, Wenzhe Jiang, Guozhen Zhang, Zhenjiang Zhao, Rui Wang, Yufang Xu, Lili Zhu, Honglin Li","doi":"10.1021/acs.jmedchem.4c02245","DOIUrl":null,"url":null,"abstract":"Rui Wang contributed to the pharmacokinetic studies and the <i>in vivo</i> models for this research and thus should be listed as an additional author, and one of the corresponding authors, of the original publication. The updated author list and Rui Wang’s Author Information are shown below: Cunjian Shi, Longfeng Chang, Jie Wang, Jingqi Dai, Wenyue Xu, Jiangyang Tang, Wenyi Mei, Chen Zhang, Zedong Wang, Yichen Liao, Xingsen Zhang, Wenzhe Jiang, Guozhen Zhang, Zhenjiang Zhao, Rui Wang,* Yufang Xu,* Lili Zhu,* and Honglin Li* <b>Rui Wang</b> – <i>Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</i>; Email: ruiwang@ecust.edu.cn This article has not yet been cited by other publications.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"12 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02245","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Rui Wang contributed to the pharmacokinetic studies and the in vivo models for this research and thus should be listed as an additional author, and one of the corresponding authors, of the original publication. The updated author list and Rui Wang’s Author Information are shown below: Cunjian Shi, Longfeng Chang, Jie Wang, Jingqi Dai, Wenyue Xu, Jiangyang Tang, Wenyi Mei, Chen Zhang, Zedong Wang, Yichen Liao, Xingsen Zhang, Wenzhe Jiang, Guozhen Zhang, Zhenjiang Zhao, Rui Wang,* Yufang Xu,* Lili Zhu,* and Honglin Li* Rui WangShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China; Email: ruiwang@ecust.edu.cn This article has not yet been cited by other publications.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对 "发现与 CD73 的 Dizinc 离子相互作用的新型非核苷抑制剂 "的更正
王锐参与了该研究的药代动力学研究和体内模型的制作,因此应被列为原始论文的附加作者和通讯作者之一。更新后的作者名单和王蕊的作者信息如下:施存健、常龙凤、王杰、戴景琦、徐文跃、唐建阳、梅文艺、张晨、王泽东、廖一晨、张兴森、蒋文哲、张国珍、赵振江、王睿、* 华东理工大学药学院新药设计上海市重点实验室,上海,200237;电子邮件:ruiwang@ecust.edu.cn 本文尚未被其他出版物引用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
期刊最新文献
Discovery, Structure-Activity Relationship, and Functional Characterization of a Chromenopyrrole Series as Orthosteric Antagonists of GPR84. Development of UM-200: A Novel Alkyne Amide-Based Inhibitor of the cGAS-STING Pathway. Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC. A Novel FXR-Targeted DUBTAC and Its Applications in Cholestasis Therapy. Design, Synthesis, and Evaluation of Phenylpyrrole Derivatives as Small-Molecule Activators of BAX.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1